Table 5.
n = 86 | Patients affected | Tolerated with premedications, n | Discontinued HD IFX, n | |
---|---|---|---|---|
n | % | |||
Acute infusion reactions | 10 | 11.6% | 9 | 1 |
Milda | 2 | 3.5% | 2 | 0 |
Moderateb | 8 | 9.3% | 7 | 1 |
Severec | 0 | 0.0% | 0 | 0 |
Delayed infusion reactions | 5 | 5.8% | 4 | 1 |
HD IFX, high dose infliximab.
aMild: hyperemia, palpitations, diaphoresis, headache, dizziness, nausea.
bModerate: mild hypo/hypertension, chest discomfort, shortness of breath, elevated temperature, palpitations, urticaria.
cSevere: significant hypo/hypertension, elevated temperature with rigors, significant shortness of breath, stridor.